Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Schwarz Pharma.
Report 1: UCB and Schwarz Pharma announce that they will start negotiations on the conclusion of a domination and profit transfer agreement between UCB SP GmbH as controlling company and Schwarz Pharma AG as controlled company.
Under German law, a domination and profit transfer agreement will enable UCB and Schwarz Pharma to operate as one fully integrated entity.
Report 2: Schwarz Pharma announced that Patrick Schwarz-Schutte...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.